QUESTION 1. Poor developing countries are critical of the TRIPS agreement for all but which one of the following reasons?
It favours large multinationals that own the most patents
It puts agriculture at risk because of seed patents owned by private-sector companies
It makes healthcare more expensive
It provides too little protection for patent holders
QUESTION 2. Large pharmaceutical companies have been caught up on scandals on all of the following except:
Improper marketing? of new drugs
Marketing activities that border on bribery
Waiting for new drug take-up by health professionals
Writing articles with misleading test results
QUESTION 3. Which of the following are more likely to foster technological innovation?
Large bureaucratic companies
Young SMEs
Family businesses
Government departments
QUESTION 4. The patent holder can do all but which one of the following?
Sell the patent
License others to utilize the patent
Control the price of the patented product in numerous markets
Launch action against counterfeiters
QUESTION 5. All but which one of the following would be classified as an 'innovation'?
A new way of communicating with customers
A new way of organizing an assembly line
A new executive team to run the company
An new marketing tool
QUESTION 6. Which of the following is potentially detrimental for developing countries that depend on low-skilled manufacturing?
They fail to grow economically
They become path-dependent
They create few jobs
They attract little FDI
QUESTION 7. Which of the following countries has been most successful in linking educational attainment with high levels of technological innovation?
South Korea
China
The UK
Japan
QUESTION 8. According to the case, CSK announced that beginning in 2016, it will no longer engage in all but which of the following:
Stop paying doctors to attend medical conferences
Stop using animals for medical testing
Stop paying doctors to speak in favour of their products
Stop paying bonuses linked to sales targets
QUESTION 9. According to the case, much of the doubtful behaviour on the part of the drug companies takes place in the following countries:
The United States
The European Union
Developing economies
Emerging economies
QUESTION 10. What type of activity do 'generic' manufacturers engage in?
Producing a product whose patent has expired
Producing a product similar to the patented one
Producing patented medicines in low-cost countries
Producing a product without permission of the patent holder